Exact Sciences Corp (NASDAQ:EXAS) has a beta value of 1.29 and has seen 6.65 million shares traded in the recent trading session. The company, currently valued at $9.37B, closed the recent trade at $50.71 per share which meant it lost -$20.8 on the day or -29.09% during that session. The EXAS stock price is -57.01% off its 52-week high price of $79.62 and 19.9% above the 52-week low of $40.62. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.64 million shares traded. The 3-month trading volume is 2.06 million shares.
The consensus among analysts is that Exact Sciences Corp (EXAS) is Buy stock at the moment, with a recommendation rating of 1.36. 0 analysts rate the stock as a Sell, while 1 rate it as Overweight. 2 out of 16 have rated it as a Hold, with 13 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.07.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exact Sciences Corp (NASDAQ:EXAS) trade information
Sporting -29.09% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the EXAS stock price touched $50.71 or saw a rise of 30.37%. Year-to-date, Exact Sciences Corp shares have moved -31.45%, while the 5-day performance has seen it change -28.03%. Over the past 30 days, the shares of Exact Sciences Corp (NASDAQ:EXAS) have changed -26.05%. Short interest in the company has seen 15.54 million shares shorted with days to cover at 7.38.
Wall Street analysts have a consensus price target for the stock at $80, which means that the shares’ value could jump 36.61% from the levels at last check today.. The projected low price target is $60.0 while the price target rests at a high of $168.0. In that case, then, we find that the latest price level in today’s session is -231.3% off the targeted high while a plunge would see the stock gain -18.32% from the levels at last check today..
Exact Sciences Corp (EXAS) estimates and forecasts
Figures show that Exact Sciences Corp shares have underperformed across the wider relevant industry. The company’s shares have lost -14.74% over the past 6 months, with this year growth rate of 15.93%, compared to 17.00% for the industry. Revenue growth from the last financial year stood is estimated to be 13.30%.
23 analysts offering their estimates for the company have set an average revenue estimate of 777.33M for the current quarter. 19 have an estimated revenue figure of 737.23M for the next ending quarter. Year-ago sales stood 646.88M and 637.52M respectively for this quarter and the next, and analysts expect sales will grow by 20.20% for the current quarter and 13.30% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 4.59% over the past 5 years.
EXAS Dividends
Exact Sciences Corp is expected to release its next earnings report on 2025-Feb-19 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Exact Sciences Corp (NASDAQ:EXAS)’s Major holders
Insiders own 1.00% of the company shares, while shares held by institutions stand at 98.49% with a share float percentage of 99.49%. Investors are also buoyed by the number of investors in a company, with Exact Sciences Corp having a total of 840.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 18.18 million shares worth more than $767.91 million. As of 2024-06-30, VANGUARD GROUP INC held 9.9672% of shares outstanding.
The other major institutional holder is CAPITAL WORLD INVESTORS, with the holding of over 16.5 million shares as of 2024-06-30. The firm’s total holdings are worth over $697.18 million and represent 9.0493% of shares outstanding.
